Image

North America Hyaluronic Acid Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

North America Hyaluronic Acid Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Published Report
  • Jan 2023
  • North America
  • 350 Pages
  • No of Tables: 217
  • No of Figures: 39

North America Hyaluronic Acid Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 3986.54 Million
Diagram Market Size (Forecast Year) USD 7960.24 Million
Diagram CAGR %

North America Hyaluronic Acid Market, By Grade (Cosmetic Grade and Pharmaceutical Grade), Type (Hydrolyzed Hyaluronic Acid, Sodium Acetylated Hyaluronic Acid, and Sodium Hyaluronate), Application (Aesthetics, Osteoarthritis, Pharmaceutical API, Cosmetics, Ophthalmology, and Others), End User (Medical Spas and Beauty Centers, Dermatology Clinics, and Cosmetic Surgery Centers), Distribution Channel (Direct Tender and Retail Sales) Industry Trends and Forecast to 2030.

Hyaluronic Acid Market

North America Hyaluronic Acid Market Analysis and Insights

Hyaluronic acid is used primarily in beauty and skin care products. It provides speedy recovery to wounds, reduces face lines, wrinkles, and skin aging, and heals cuts and burns among others. It contains vitamin C for brightening skin tone. Beauty products containing hyaluronic acid give nourishment to the skin when applied in the form of moisturizers, creams, skin toners, and serums among others.

Hyaluronic Acid Market

Hyaluronic Acid Market

Data Bridge Market Research analyzes that the market is growing with a CAGR of 9.0% in the forecast period of 2023 to 2030 and is expected to reach USD 7,960.24 million by 2030 from USD 3,986.54 million in 2022.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2020-2016)

Quantitative Units

Revenue in USD Million

Segments Covered

By Grade (Cosmetic Grade and Pharmaceutical Grade), Type (Hydrolyzed Hyaluronic Acid, Sodium Acetylated Hyaluronic Acid, and Sodium Hyaluronate), Application (Aesthetics, Osteoarthritis, Pharmaceutical API, Cosmetics, Ophthalmology, and Others), End User (Medical Spas and Beauty Centers, Dermatology Clinics, and Cosmetic Surgery Centers), Distribution Channel (Direct Tender and Retail Sales).

Countries Covered

U.S., Canada, and Mexico.

Market Players Covered

Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro a.s., Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA s.r.l., Symatese, Stanford Chemicals owned by Oceania International LLC, Bioiberica S.A.U., GENESIS pharmacy services, and Brickell Men's Products among others

Market Definition

Hyaluronic Acid (HA) also called hyaluronan, is an anionic, non-sulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. An essential component of articular cartilage, hyaluronic acid surrounds each cell in the cartilage like a coat (chondrocyte). The robustness of cartilage is due to these aggregates' ingestion of water (its resistance to compression). The molecular weight (size) of hyaluronan in cartilage decreases with age, but the amount increases. The human body naturally contains HA. The largest quantities of HA are seen in the joints and eyes. The chemical has the capacity to maintain luscious, moisturized skin. As a result, it is used by many cosmetic surgeons as an injectable to delay the signs of aging on the skin.

The increasing prevalence of minimally invasive procedures and rising awareness and demand for hyaluronic acid in pharmaceutical and cosmetic products across the globe are major driving factors for market growth in the forecast period. The dramatic rise in the quality of research coupled with increasing research opportunities is because of various strategic initiatives taken by the market players. They are taking initiatives such as product launches, collaborations, mergers, acquisitions, and many more over the years and are expected to lead and create more opportunities in the market.

North America Hyaluronic Acid Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

  • Increasing Awareness Towards Cosmetic Injectables or Dermal Fillers

Hyaluronic acid-based dermal fillers are the less invasive cosmetic processes. Dermatology problems are common across the globe. It has become a major concern to understand the products to treat skin-related problems and restore skin wrinkles. Various programs have been launched to create awareness about the proper use of hyaluronic acid injectables.

The increased consciousness will enable the consumers to opt for the correct treatment of acne and wrinkles and to select the right product (Botox injection, dermal fillers) as per the correct cause. This will lead to a rise in sales, a rise in the product portfolio, and an expansion of the product line. This factor is expected to propel the market growth.

  • Use of Invasive Hyaluronic Acid Based Dermal Fillers

Hyaluronic acid-based dermal fillers are less invasive cosmetic processes, which are promptly increasing across the globe. These are popular cosmetic procedures for facial renovation, face volume restoration, and aesthetic improvement.

They are quite versatile and they are used on fine lines and wrinkles. In addition, these are also used for treating acne, wrinkles, and scars and for lip, cheek, and chin augmentation. The rise in the geriatric population has uplifted the necessity of non-invasive surgical protocols.

The implementation of hyaluronic acid-based dermal fillers will reduce the chances to opt for normal surgery. There is a minimum cost of treatment and this factor will boost the market growth.

RESTRAINTS

  • Availability of Unauthorized or Alternative Dermal Fillers to Hamper Market

With the widespread accessibility of the aesthetic application of Hyaluronic acid-based dermal fillers, several limiting factors of these products are projected to hamper the North America market growth in the coming years.

Due to the high efficacy rate, patient satisfaction, and usage in dynamic wrinkles, botulinum toxin type, a dermal filler, is leading the non-surgical cosmetic procedure worldwide.

Furthermore, other biodegradable fillers, such as Calcium Hydroxyapatite (CaHA) and Poly-L-Latic acid are gaining popularity as alternative fillers used as implants with high longevity.

The reluctance among physicians has been observed to use low-cost illegal products, due to the risks involved in it. Conversely, the illegal products being available in the dermal filler segment will increase the competition in price, especially in the hyaluronic acid segment. Larger companies that provide high prices per unit have the ability to compete by offering multiple product bundles and selling products among various product divisions.

To compensate for fewer prices in hyaluronic acid dermal fillers, the particle and polymer manufacturers will have to promote the products. The products available in the segment vary. The manufacturers will focus more on the material strength used in dermal fillers, rather than on the cost price.

OPPORTUNITIES

  • New Technology and Developments in Hyaluronic Acid Products

Advanced innovative technologies have improved aesthetic treatment for skin and other body parts wherever necessary and the skincare industry is one of the most rapidly changing ones. Homegrown brands with actives, ingredient-based skincare, and the beauty space are witnessing the rise of investment, and the consumer is keenly involved. The advanced innovative technology and developments of hyaluronic acid-based products boost the demand for hyaluronic acid in the market.

Hyaluronic dermal products are based on hyaluronic acid that corrects facial imperfections, compensates for volume, and emphasizes certain areas of the face. Advancement in dermal products offers an effective way to enhance, restore, and define facial features. Advancement in hyaluronic acid-based products and procedure of dermal fillers attracts customers toward cosmetics. Thus, it signifies that technological advancement in hyaluronic dermal products is expected to act as an opportunity for market growth.

CHALLENGES

  • Escalating Product Recall

The recall of Hyaluronic acid-based products has greatly impacted the market growth. Regulatory authorities recall aesthetic and cosmetic products due to health and safety issues. Every country has its own regulatory authority which is responsible for monitoring the regulation of healthcare-related products.

Product recall by the companies or by the regulatory authorities for patient health safety concerns such as the inaccuracy of content or ingredient error are a few of the major concerns that act as a challenge to market growth as the patient’s safety and health are the most important criteria for any market introducing their products in the market.

Recent Developments

  • In February 2022, Allergan (a subsidiary of AbbVie Inc.) announced the FDA approval of JUVÉDERM VOLBELLA XC for the improvement of infraorbital hollows in adults aged above 21. This helped the company to expand its product portfolio of aesthetics in the U.S. market.
  • In February 2021, Contipro, a renowned hyaluronic acid manufacturer based in the Czech Republic, announced the launch of its new anti-aging and anti-acne treatment product called HyRetin, which improves the visibility of the skin.

North America Hyaluronic Acid Market Scope

North America hyaluronic acid market is segmented into five notable segments based on grade, type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Grade

  • Cosmetic Grade
  • Pharmaceutical Grade

Based on grade, the market is segmented into cosmetic grade and pharmaceutical grade.

Type

  • Hydrolyzed Hyaluronic Acid
  • Sodium Acetylated Hyaluronic Acid
  • Sodium Hyaluronate

Based on type, the market is segmented into hydrolyzed hyaluronic acid, sodium acetylated hyaluronic acid, and sodium hyaluronate.

Application

  • Aesthetics
  • Osteoarthritis
  • Pharmaceutical API
  • Cosmetics
  • Ophthalmology
  • Others

Based on application, the market is segmented into aesthetics, osteoarthritis, pharmaceutical API, cosmetics, ophthalmology, and others.

End User

  • Pharmaceutical Industry
  • Dermatology Clinics
  • Cosmetic Surgery Centers
  • Others

Based on end user, the market is segmented into pharmaceutical industry, dermatology clinics, cosmetic surgery centers, and others.

Distribution Channel

  • Direct Tender
  • Retail Sales

Based on distribution channel, the market is segmented into direct tender and retail sales.

North America Hyaluronic Acid Market Regional Analysis/Insights    

The North America hyaluronic acid market is analyzed, and market size insights and trends are provided by country, grade, type, application, end user, and distribution channel as referenced above.

The countries covered in this market report are the U.S., Canada, and Mexico.

  • In 2023, the U.S. is dominating the North America hyaluronic acid market in terms of market share and revenue and will continue to flourish its dominance during the forecast period. This is due to increasing awareness towards cosmetic injectables or dermal fillers in the region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of North America brands and their challenges faced due to competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and North America Hyaluronic Acid Market Share Analysis

The North America hyaluronic acid market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the North America hyaluronic acid market are Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro a.s., Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA s.r.l., Symatese, Stanford Chemicals owned by Oceania International LLC, Bioiberica S.A.U., GENESIS pharmacy services, and Brickell Men's Products among others.


SKU-

TABLE 1 U.S. AESTHETIC PLASTIC SURGERY PROCEDURES COUNT IN 2021 AND 2020:

TABLE 2 REQUIRED TIME, NUMBER OF TREATMENTS, REST TIME

TABLE 3 NORTH AMERICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 4 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 12 NORTH AMERICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 13 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 14 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 15 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 16 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 17 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 18 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 19 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 21 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 33 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 34 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 35 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 NORTH AMERICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 38 NORTH AMERICA AESTHETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 NORTH AMERICA OSTEOARTHRITIS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 NORTH AMERICA COSMETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 NORTH AMERICA OPHTHALMOLOGY IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 NORTH AMERICA PHARMACEUTICAL API IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 43 NORTH AMERICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 NORTH AMERICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 45 NORTH AMERICA DERMATOLOGY CLINICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 NORTH AMERICA COSMETIC SURGERY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 47 NORTH AMERICA MEDICAL SPAS AND BEAUTY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 NORTH AMERICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 NORTH AMERICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 50 NORTH AMERICA RETAIL SALES IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 NORTH AMERICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 52 NORTH AMERICA DIRECT TENDER IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 NORTH AMERICA HYALURONIC ACID MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 54 NORTH AMERICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 55 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 56 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 57 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 58 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 59 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 60 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 62 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 63 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 65 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 66 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 67 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 68 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 69 NORTH AMERICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 70 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 71 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 72 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 73 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 74 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 75 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 76 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 77 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 78 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 79 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 80 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 82 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 NORTH AMERICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 84 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 85 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 86 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 87 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 88 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 89 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 90 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 91 NORTH AMERICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 92 NORTH AMERICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 93 NORTH AMERICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 94 NORTH AMERICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 95 U.S. HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 96 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 97 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 98 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 99 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 100 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 101 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 102 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 103 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 104 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 105 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 106 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 107 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 108 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 109 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 110 U.S. HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 111 U.S. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 112 U.S. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 113 U.S. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 114 U.S. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 115 U.S. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 116 U.S. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 117 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 118 U.S. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 119 U.S. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 120 U.S. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 121 U.S. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 U.S. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 U.S. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 124 U.S. INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 125 U.S. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 126 U.S. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 127 U.S. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 128 U.S. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 129 U.S. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 130 U.S. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 131 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 U.S. HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 133 U.S. HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 134 U.S. HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 135 U.S. RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 136 CANADA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 137 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 138 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 140 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 141 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 142 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 143 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 144 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 145 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 146 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 147 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 148 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 150 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 151 CANADA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 152 CANADA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 153 CANADA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 154 CANADA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 155 CANADA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 156 CANADA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 157 CANADA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 158 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 159 CANADA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 160 CANADA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 CANADA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 162 CANADA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 163 CANADA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 164 CANADA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 165 CANADA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 166 CANADA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 167 CANADA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 168 CANADA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 169 CANADA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 170 CANADA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 171 CANADA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 172 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 173 CANADA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 CANADA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 175 CANADA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 176 CANADA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 177 MEXICO HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 178 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 179 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 180 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 181 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 182 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 183 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 184 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 185 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 186 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 187 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 188 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 189 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 191 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 192 MEXICO HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 193 MEXICO SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 194 MEXICO SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 195 MEXICO COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 196 MEXICO COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 197 MEXICO PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 198 MEXICO PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 200 MEXICO HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 201 MEXICO HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 202 MEXICO COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 203 MEXICO COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 MEXICO PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 205 MEXICO PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 206 MEXICO INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 MEXICO SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 208 MEXICO SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 MEXICO COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 210 MEXICO COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 MEXICO PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 212 MEXICO PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 213 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 MEXICO HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 215 MEXICO HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 216 MEXICO HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 217 MEXICO RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The North America Hyaluronic Acid Market is projected to grow at a CAGR of 9.0% during the forecast period by 2030.
The future market value of the North America Hyaluronic Acid Market is expected to reach USD 7,960.24 million by 2030.
The major players in the North America Hyaluronic Acid Market are Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., etc.
The countries covered in the North America Hyaluronic Acid Market are U.S., Canada, and Mexico.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials